It’s essential that leaders in neurotechnology - companies, investors, scientists, and more - know about, and shape, public policy and industry standards. Dr. Rafael Yuste along with Jamie Daves came together for a behind-the-scenes briefing on the latest developments in US and global regulation and industry practice. This session covers the recent precedent-setting Colorado neurotech legislation, and highlights what’s coming next in the US and around the world. Dr. Karen Rommelfanger moderates an interactive discussion on strategies all stakeholders can use to navigate the emerging regulatory and industry environments, advance innovation, and foster public trust. Participants will be encouraged to pose questions, share experiences, and engage in debate. This session was a critical opportunity for all stakeholders to learn more, and get involved in determining what comes next.
Rafael Yuste, MD, PhD (Columbia University, Neurorights Foundation)
ntc.columbia.e...
Karen Rommelfanger, PhD(Institute of Neuroethics Think and Do Tank, Ningen Neuroethics Co-Lab)
instituteofneu...
Jamie Daves, MBA (Neurorights Foundation)
www.jamiedaves...
********
BrainMind is a platform and private community of top brain scientists, entrepreneurs, investors, philanthropists, and academic institutions collaborating to accelerate impactful innovation in brain science.
www.brainmind....
Apply to become a member of the BrainMind ecosystem:
www.brainmind....
Негізгі бет The First Brain Data Law Just Passed. What Do You Need to Know - and What’s Next?
Пікірлер: 15